Colgate-Palmolive Company (CL) : Elm Advisors reduced its stake in Colgate-Palmolive Company by 6.38% during the most recent quarter end. The investment management company now holds a total of 4,400 shares of Colgate-Palmolive Company which is valued at $317,680 after selling 300 shares in Colgate-Palmolive Company , the firm said in a disclosure report filed with the SEC on Oct 12, 2016.Colgate-Palmolive Company makes up approximately 0.30% of Elm Advisors’s portfolio.
Other Hedge Funds, Including , Baltimore-washington Financial Advisors reduced its stake in CL by selling 569 shares or 0.77% in the most recent quarter. The Hedge Fund company now holds 73,532 shares of CL which is valued at $5,309,010. Colgate-Palmolive Company makes up approx 1.54% of Baltimore-washington Financial Advisors’s portfolio.Contravisory Investment Management reduced its stake in CL by selling 29 shares or 1.78% in the most recent quarter. The Hedge Fund company now holds 1,600 shares of CL which is valued at $116,176. Colgate-Palmolive Company makes up approx 0.04% of Contravisory Investment Management’s portfolio.North Star Asset Management Inc reduced its stake in CL by selling 50 shares or 0.72% in the most recent quarter. The Hedge Fund company now holds 6,892 shares of CL which is valued at $502,909. Colgate-Palmolive Company makes up approx 0.06% of North Star Asset Management Inc’s portfolio.Chevy Chase Trust Holdings reduced its stake in CL by selling 18,862 shares or 2.37% in the most recent quarter. The Hedge Fund company now holds 776,616 shares of CL which is valued at $56,669,670. Colgate-Palmolive Company makes up approx 0.31% of Chevy Chase Trust Holdings’s portfolio.
Colgate-Palmolive Company closed down -0.41 points or -0.56% at $72.2 with 29,71,861 shares getting traded on Tuesday. Post opening the session at $72.54, the shares hit an intraday low of $71.89 and an intraday high of $72.63 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, Colgate-Palmolive Company reported $0.70 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.69. The company had revenue of $3845.00 million for the quarter, compared to analysts expectations of $3859.81 million. The company’s revenue was down -5.4 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.70 EPS.
Investors should note that on Sep 8, 2016, Colgate-Palmolive Company announced a cash dividend of $0.3900. The company’s management has announced Oct 20, 2016 as the ex-dividend date and fixed the record date on Oct 24, 2016. The payable date has been fixed on Nov 15, 2016.
Many Wall Street Analysts have commented on Colgate-Palmolive Company. Colgate-Palmolive Company was Upgraded by BofA/Merrill to ” Buy” on Sep 12, 2016. Colgate-Palmolive Company was Downgraded by Exane BNP Paribas to ” Neutral” on Jul 29, 2016.
Colgate-Palmolive Company (Colgate) is a consumer products company whose products are marketed in more than 200 countries and territories throughout the world. The Company operates in two product segments: Oral Personal and Home Care and Pet Nutrition. The Oral Personal and Home Care product segment is operated through five geographic segments: North America Latin America Europe/South Pacific Asia and Africa/Eurasia. The Company’s oral care products include Colgate Total; Colgate Sensitive Pro-Relief; Colgate Max Fresh; Colgate Optic White and Colgate Luminous White toothpastes among others. The Company sells its personal care products under the Palmolive Protex and Softsoap brands. The Company through its Hill’s Pet Nutrition segment (Hill’s) manufactures pet nutrition products for dogs and cats.